Literature DB >> 32990800

LncRNA PCAT6 Regulated by YY1 Accelerates the Progression of Glioblastoma via miR-513/IGF2BP1.

Peng Liu1, Peng Zhao1, Bing Li1, Dianxiang Xu2, Kun Wang3.   

Abstract

Glioblastoma is one of the most frequent and aggressive primary tumor of glial brain tumors. Long non-coding RNA Prostate cancer-associated ncRNA transcript 6 (PCAT6) has been identified to influence the progression of many cancers, but its expression and functions in glioblastoma remain unclear. In this study, we intended to investigate the expression, functions and the corresponding mechanisms of PCAT6 in glioblastoma. We observed that PCAT6 expression was upregulated in glioblastoma tissues and cell lines and its high expression was due to the transcriptional activation by Yin Yang 1. miR-513 was a target of PCAT6 and Insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) was a target of miR-513. Hence, PCAT6 upregulated IGF2BP1 expression via miR-513 in a competing endogenous RNAs manner. PCAT6 and IGF2BP1 functioned as oncogenes while miR-513 acted as a tumor suppressor gene in glioblastoma. PCAT6 and miR-513 modulated the proliferation and survival of glioblastoma cells via AKT signaling by mediating IGF2BP1. IGF2BP1 raised the expression of PCAT6 by increasing its stability. In conclusion, our results indicate that PCAT6/miR-513/IGF2BP1 positive feedback loop plays a crucial role in facilitating glioblastoma progression.

Entities:  

Keywords:  Glioblastoma; IGF2BP1; Long non-coding RNA; PCAT6; Yin yang 1; miR-513

Mesh:

Substances:

Year:  2020        PMID: 32990800     DOI: 10.1007/s11064-020-03138-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  6 in total

1.  A Novel Pyroptosis-Associated Long Noncoding RNA Signature to Predict the Prognosis of Patients with Colorectal Cancer.

Authors:  Sijun Chen; Jianwei Zhu; Xiaofei Zhi
Journal:  Int J Gen Med       Date:  2021-09-27

Review 2.  The Roles and Regulation of m6A Modification in Glioblastoma Stem Cells and Tumorigenesis.

Authors:  Peng Li; Hope T Richard; Kezhou Zhu; Linlin Li; Suyun Huang
Journal:  Biomedicines       Date:  2022-04-22

Review 3.  PCAT6 May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers.

Authors:  Feng Jiang; Qiaoyi Lv; Cexun Hu; Zhanghui Li; Haojie Wu; Shujun Gao; Hui Wang; Yangjing Zhao; Qixiang Shao
Journal:  Cancers (Basel)       Date:  2021-12-03       Impact factor: 6.639

4.  Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway.

Authors:  Jiewei Lin; Shuyu Zhai; Siyi Zou; Zhiwei Xu; Jun Zhang; Lingxi Jiang; Xiaxing Deng; Hao Chen; Chenghong Peng; Jiaqiang Zhang; Baiyong Shen
Journal:  J Exp Clin Cancer Res       Date:  2021-10-11

Review 5.  PCAT6 may be a new prognostic biomarker in various cancers: a meta-analysis and bioinformatics analysis.

Authors:  Song-Bo Shi; Qing-Hao Cheng; Shi-Yi Gong; Ting-Ting Lu; Shi-Fang Guo; Shao-Ming Song; Yu-Ping Yang; Qi Cui; Ke-Hu Yang; Yao-Wen Qian
Journal:  Cancer Cell Int       Date:  2021-07-12       Impact factor: 5.722

Review 6.  The Role of lncRNA PCAT6 in Cancers.

Authors:  Siying Wang; Zhenyao Chen; Jingyao Gu; Xin Chen; Zhaoxia Wang
Journal:  Front Oncol       Date:  2021-07-13       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.